Marriage reduces the risk of heart attack in both men and women and at all ages

January 31, 2013 in Cardiology

A large population-based study from Finland has shown that being unmarried increases the risk of fatal and non-fatal heart attack in both men and women whatever their age. Conversely, say the study investigators, especially among middle-aged couples, being married and cohabiting are associated with "considerably better prognosis of acute cardiac events both before hospitalization and after reaching the hospital alive".

The study, published today in the European Journal of Preventive Cardiology, was based on the FINAMI register data from the years 1993 to 2002.(1,2) The study included information on people over the age of 35 living in four of Finland. All fatal and non-fatal - known as "acute cardiac syndromes", ACS - were included and cross-referred to the population database. "Our aim," said the authors, "was to study the differences in the morbidity and prognosis of incident according to socio- (marital status and household size)."

The register recorded 15,330 ACS events over the study period of ten years, with just over half (7703) resulting in death within 28 days. Events occurred almost equally among men and women. However, the analysis also showed that the age-standardised incidences of these ACS events were approximately 58–66% higher among unmarried men and 60–65% higher in , than among and women in all age groups.

The differences in 28-day mortality rate were even greater. These 28-day mortality rates were found to be 60–168% higher in unmarried men and 71–175% higher in unmarried women, than among married men and women.

For example, the 28-day ACS mortality rate in 65-74-year-old married men was 866 per 100,000 persons per year but 1792 per 100,000 per year in unmarried men. This rate did not differ according to previous marital status.

Similarly, among 65-74-year old were 247 per 100,000 persons per year, but 493 per 100,000 when the woman was unmarried. Statistically, the figures represented a 28-day "case fatality" rate of 26% in the 35-64-year-old married men, 42% in men who had previously been married, and 51% in never-married men. Among women, the corresponding figures were 20%, 32%, and 43%.

Consistent with this finding, the case fatality rate of 35-64-year-old single men and women was higher than that of those living with one or more people.

According to the authors' background to the study, being unmarried or living alone is known to increase total and cardiovascular mortality and cardiovascular disease incidence. However, many of these previous studies have included only men in their analysis, with missing data on and older age groups.

Why should single living or being unmarried be associated with such a greater susceptibility to coronary events, and particularly fatal events? The authors suggest several possibilities:

  • Differences in the prevalence of traditional cardiovascular risk factors. "We cannot exclude the possibility that persons with poor health status may be more prone to staying unmarried or getting divorced," the authors state.
  • Married people may be better off, have better health habits, and enjoy higher levels of social support than the unmarried, which will all promote their overall health.
  • Better prospects in the pre-hospital phase because of earlier intervention. "It may be assumed that resuscitation or calling for help was initiated faster and more often among those married or cohabiting," say the authors.
  • Better treatment once in hospital and after discharge. "We found that a larger proportion of married and cohabiting received reperfusion therapy at acute stage which may contribute to their better survival after hospitalisation. Lower adherence to secondary preventive medications (aspirin, statins, beta-blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers) among the unmarried may have an adverse effect on long-term prognosis," they add.
However, lead author Dr Aino Lammintausta from Turku University Hospital in Finland also notes that these differences in prognosis cannot be fully explained by differences in treatment-seeking time or access to effective therapy. The socio-demographic differences reflected in the study's results are a "considerable population health problem", she said, which warrants further research to explain.

More information: Lammintausta A, Airaksinen KEJ, Immonen-Raiha P, et al. Prognosis of acute coronary events is worse in patients living alone: the FINAMI myocardial infarction register, Eur J Prevent Cardiol 2012; DOI: 10.1177/2047487313475893

Journal reference: European Journal of Preventive Cardiology search and more info website

Provided by European Society of Cardiology search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Second-generation TAVI device—Lotus Valve—shows good performance in REPRISE II

22 May 2013, Paris, France: The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted in all of the first 60 patients in results from REPRISE II reported at EuroPCR ...

Cardiology created 12 minutes ago | popularity not rated yet | comments 0

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 23 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created May 22, 2013 | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created May 22, 2013 | popularity 5 / 5 (1) | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created May 22, 2013 | popularity not rated yet | comments 0


Researchers suggest boosting body's natural flu killers

A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have ...

Major human drug trial underway for Alzheimer's

A potentially ground-breaking human drug trial is currently underway, which aims to discover whether blood pressure medication can slow or halt the progression of Alzheimer's Disease (AD). This is the latest ...

Pay attention: How we focus and concentrate

Scientists at Newcastle University have shed new light on how the brain tunes in to relevant information.

New discovery in fight against deadly meningococcal disease

Professor Michael Jennings, Deputy Director of the Institute for Glycomics at Griffith University, was part of an international team that discovered the previously unknown pathway of how the bacterium colonizes people.

Are kids who take music lessons different from other kids?

(Medical Xpress)—Research by U of T Mississauga psychology professor Glenn Schellenberg reveals that two key personality traits – openness-to-experience and conscientiousness—predict better than IQ ...

Study reveals active site of enzyme linked to stuttering

(Medical Xpress)—Scientists from the Joint Center for Structural Genomics (JCSG) at SLAC National Accelerator Laboratory have determined the 3-D structure of the chemically active part of an enzyme involved ...